Chronic obstructive pulmonary disease laboratory findings: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Chronic obstructive pulmonary disease}} | {{Chronic obstructive pulmonary disease}} | ||
{{CMG}}; [[Philip Marcus, M.D., M.P.H.]] [mailto:pmarcus192@aol.com]; {{AOEIC}} {{CZ}} | {{CMG}}; [[Philip Marcus, M.D., M.P.H.]] [mailto:pmarcus192@aol.com]; {{AOEIC}} {{CZ}} | ||
| Line 6: | Line 7: | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
===Pulse | ===Pulse Oximetry=== | ||
* Though pulse oximetry is not as accurate in predicting the percentage oxygen saturation as arterial blood gas analysis. However, it gives a quick estimate of patient status when combined with the clinical status. | * Though pulse oximetry is not as accurate in predicting the percentage oxygen saturation as arterial blood gas analysis. However, it gives a quick estimate of patient status when combined with the clinical status. | ||
===Arterial | ===Arterial Blood Gas (ABG)=== | ||
* ABG may show changes of hypoxemia and hypercapnia depending on the severity of disease. | * ABG may show changes of hypoxemia and hypercapnia depending on the severity of disease. | ||
* Milder exacerbation may present only with hypoxemia without accompanied hypercapnia | * Milder exacerbation may present only with hypoxemia without accompanied hypercapnia | ||
| Line 16: | Line 17: | ||
* COPD patients may have hypoxemia due to the chronic underlying disease. This chronic hypoxemia may lead to polycythemia (hematocrit > 52% in men or 47% in women is diagnostic of polycythemia. | * COPD patients may have hypoxemia due to the chronic underlying disease. This chronic hypoxemia may lead to polycythemia (hematocrit > 52% in men or 47% in women is diagnostic of polycythemia. | ||
* Correction of hypoxemia should reduce secondary polycythemia in patients who have quit smoking. | * Correction of hypoxemia should reduce secondary polycythemia in patients who have quit smoking. | ||
===Blood | ===Blood Test=== | ||
* A [[blood test]] would indicate inflammation (as indicated by a raised [[white blood cell]] count and elevated [[C-reactive protein]]). | * A [[blood test]] would indicate inflammation (as indicated by a raised [[white blood cell]] count and elevated [[C-reactive protein]]). | ||
**Neutrophils infiltrate the lung tissue, aided by damage to the airways caused by irritation. | **Neutrophils infiltrate the lung tissue, aided by damage to the airways caused by irritation. | ||
| Line 23: | Line 24: | ||
**Further obstruction to the airways is caused by more goblet cells in the small airways. This is typical of chronic bronchitis | **Further obstruction to the airways is caused by more goblet cells in the small airways. This is typical of chronic bronchitis | ||
**Although infection is not the reason or cause of chronic bronchitis it is seen to aid in sustaining the bronchitis.''''' | **Although infection is not the reason or cause of chronic bronchitis it is seen to aid in sustaining the bronchitis.''''' | ||
===Serum | ===Serum Electrolytes=== | ||
COPD patients have irreversible obstruction of airway that causes retention of carbon-dioxide. This in turn causes them to develop chronic respiratory acidosis. To compensate for this the body may develop metabolic alkalosis that leads to increased bicarbonate production. Bicarbonate levels act as useful indicator of disease progression. | COPD patients have irreversible obstruction of airway that causes retention of carbon-dioxide. This in turn causes them to develop chronic respiratory acidosis. To compensate for this the body may develop metabolic alkalosis that leads to increased bicarbonate production. Bicarbonate levels act as useful indicator of disease progression. | ||
===Sputum | ===Sputum Culture=== | ||
* Though sputum culture can be done and yields organisms like Streptococcus pneumonia, and Hemophilus influenza during acute exacerbation, they are not otherwise useful in management plans. | * Though sputum culture can be done and yields organisms like Streptococcus pneumonia, and Hemophilus influenza during acute exacerbation, they are not otherwise useful in management plans. | ||
* A sputum sample showing [[neutrophil granulocyte]]s (inflammatory white blood cells) and [[microbiological culture|culture]] showing that has pathogenic microorganisms such as [[Streptococcus|Streptococcus spp.]] | * A sputum sample showing [[neutrophil granulocyte]]s (inflammatory white blood cells) and [[microbiological culture|culture]] showing that has pathogenic microorganisms such as [[Streptococcus|Streptococcus spp.]] | ||
===Human B-type | ===Human B-type Natriuretic Peptide=== | ||
* Research are ongoing on Human B-type natriuretic peptide (BNP) and pro-BNP to find if it can help to differentiate between congestive heart failure and COPD. However, no conclusive results are still drawn. | * Research are ongoing on Human B-type natriuretic peptide (BNP) and pro-BNP to find if it can help to differentiate between congestive heart failure and COPD. However, no conclusive results are still drawn. | ||
===Alpha 1 | ===Alpha 1 Antitrypsin Levels=== | ||
* Serum alpha1-antitrypsin levels below the protective threshold value (ie, 3-7 mmol/L) lead to severe form of emphysema | * Serum alpha1-antitrypsin levels below the protective threshold value (ie, 3-7 mmol/L) lead to severe form of emphysema | ||
* 95% cases are due to the severe variant the Z allele present in these patients. | * 95% cases are due to the severe variant the Z allele present in these patients. | ||
| Line 45: | Line 46: | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Primary care]] | |||
Revision as of 20:55, 26 February 2013
|
Chronic obstructive pulmonary disease Microchapters |
|
Differentiating Chronic obstructive pulmonary disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic obstructive pulmonary disease laboratory findings On the Web |
|
American Roentgen Ray Society Images of Chronic obstructive pulmonary disease laboratory findings |
|
FDA on Chronic obstructive pulmonary disease laboratory findings |
|
CDC on Chronic obstructive pulmonary disease laboratory findings |
|
Chronic obstructive pulmonary disease laboratory findings in the news |
|
Blogs on Chronic obstructive pulmonary disease laboratory findings |
|
Directions to Hospitals Treating Chronic obstructive pulmonary disease |
|
Risk calculators and risk factors for Chronic obstructive pulmonary disease laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Philip Marcus, M.D., M.P.H. [2]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Overview
Chronic obstructive pulmonary disease has irreversible airflow limitation specially during forced expiration. This is due to the destruction of lung tissue and increase in resistance to flow in the conducting airways. Thus, it doesn't show an improvement in FEV1 post bronchodilator administration (unlike asthma). This characteristic feature is used as an diagnostic criteria for COPD, i.e. a COPD is diagnosed by spirometry if FEV1/FVC < 70% for a matched control. Arterial blood gas may show hypoxemia with or without hypercapnia depending on the disease severity. pH may be normal due to renal compensation. A pH less than 7.3 usually indicate severe respiratory compromise. A blood sample taken from an artery, i.e. Arterial Blood Gas (ABG), can be tested for blood gas levels which may show low oxygen (hypoxaemia) and/or high carbon dioxide (respiratory acidosis if pH is also decreased). A blood sample taken from a vein may show a high blood count (reactive polycythemia), a reaction to long-term hypoxemia.
Laboratory Findings
Pulse Oximetry
- Though pulse oximetry is not as accurate in predicting the percentage oxygen saturation as arterial blood gas analysis. However, it gives a quick estimate of patient status when combined with the clinical status.
Arterial Blood Gas (ABG)
- ABG may show changes of hypoxemia and hypercapnia depending on the severity of disease.
- Milder exacerbation may present only with hypoxemia without accompanied hypercapnia
- Hypercapnia is usually seen when FEV1 falls below 1 L/s or 30% of the predicted value
- A pH value below 7.3 usually indicates a severe exacerbation and respiratory compromise.
Hematocrit
- COPD patients may have hypoxemia due to the chronic underlying disease. This chronic hypoxemia may lead to polycythemia (hematocrit > 52% in men or 47% in women is diagnostic of polycythemia.
- Correction of hypoxemia should reduce secondary polycythemia in patients who have quit smoking.
Blood Test
- A blood test would indicate inflammation (as indicated by a raised white blood cell count and elevated C-reactive protein).
- Neutrophils infiltrate the lung tissue, aided by damage to the airways caused by irritation.
- Damage caused by irritation of the airways leads to inflammation and leads to neutrophils being present
- Mucosal hypersecretion is promoted by a substance released by neutrophils
- Further obstruction to the airways is caused by more goblet cells in the small airways. This is typical of chronic bronchitis
- Although infection is not the reason or cause of chronic bronchitis it is seen to aid in sustaining the bronchitis.
Serum Electrolytes
COPD patients have irreversible obstruction of airway that causes retention of carbon-dioxide. This in turn causes them to develop chronic respiratory acidosis. To compensate for this the body may develop metabolic alkalosis that leads to increased bicarbonate production. Bicarbonate levels act as useful indicator of disease progression.
Sputum Culture
- Though sputum culture can be done and yields organisms like Streptococcus pneumonia, and Hemophilus influenza during acute exacerbation, they are not otherwise useful in management plans.
- A sputum sample showing neutrophil granulocytes (inflammatory white blood cells) and culture showing that has pathogenic microorganisms such as Streptococcus spp.
Human B-type Natriuretic Peptide
- Research are ongoing on Human B-type natriuretic peptide (BNP) and pro-BNP to find if it can help to differentiate between congestive heart failure and COPD. However, no conclusive results are still drawn.
Alpha 1 Antitrypsin Levels
- Serum alpha1-antitrypsin levels below the protective threshold value (ie, 3-7 mmol/L) lead to severe form of emphysema
- 95% cases are due to the severe variant the Z allele present in these patients.
- Specific phenotyping, and genetic counselling is reserved for patients in whom serum levels are 7-11 mmol/L.